Slideshow

5 Classic Hallucinogens Studied in the Treatment of Addictions

Author(s):

Michael P. Bogenschutz, MD

This slideshow provides information about the compounds, clinically relevant attributes, approximate dose, and data under study.

Related Videos
brain
nicotine use
Related Content
F. Gerard Moeller, M.D.
December 9th 2024

Beyond Abstinence: Other Clinically Meaningful Endpoints for Patients With Substance Use Disorders

F. Gerard Moeller, MD
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
cocaine
October 7th 2024

A Randomized Controlled Trial of Lorcaserin in Cocaine Use Disorder

Brian Miller, MD, PhD, MPH
Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic
March 19th 2021

Lloyd Sederer, MD: A Conversation About Addiction and the Opioid Epidemic

Angela A. Coombs, MD Jennifer Sotsky, MD, MS
nitrous oxide
September 24th 2024

Galaxy Gas: The Dangerous Viral Trend

Lindsi Filippi, BA Nicholas Pratt, MD, RN
end of life
September 20th 2024

End-of-Life Care for Patients With Psychiatric Disorders

Joel Yager, MD Jonathan Treem, MD Thomas Strouse, MD
© 2024 MJH Life Sciences

All rights reserved.